Insights
Blogs, articles and knowledge series
Articles from K&G Techlaw Partners on pharmaceutical, healthcare, technology and regulatory law in India.
Showing 48 articles.
Medical Devices (Amendment) Rules, 2026: How CDSCO’s Faster Licensing Timelines Reshape Manufacturing Compliance
Jan Vishwas 2.0: What the New Decriminalisation Law Means for the Pharma Industry
DPCO Amendment 2026: What NPPA’s New Overcharging and Compliance Rules Mean for Pharma Companies
Form 11 Drug Import India: CDSCO’s 2026 Proposed Amendment Explained for Pharma Companies
Schedule K Amendment: What the Deletion of ‘Syrup’ Really Means for India’s Drug Retail Landscape
Schedule H2 Expanded: QR Code Drug Traceability Now Covers Vaccines, Antimicrobials and Anti-Cancer Medicines in India
CDSCO Tightens Compliance: Why Is Pharmacovigilance Important for All Pharma Companies Now?
Recent Updates in India’s Medical Device Regulation in India and IVD Regulatory Landscape — CDSCO Latest Circulars & Compliance Advisory
Notification on Prohibited Drugs: Nimesulide, Chloramphenicol, and Nitrofurans — A Drug Law Advisory Under Drugs and Cosmetics Rules Legal Advisory
Indian Pharmaceutical Policy Landscape: A Pharmaceutical Law Firm India and Health Care Law Guide
Compliance and Risk Management in Indian Pharma & MedTech: A Health Care Law and CDSCO Regulatory Lawyer India Perspective
Life Sciences & Biotechnology Compliance in India: A Healthcare Law Firm India and Healthcare Legal Advisory Guide
Governing Synthetic Media: Deepfakes, AI-Generated Content, and India’s Evolving Cyberlaw and Legal Framework
E Pharmacy & Digital Health Policies in India: A Pharmaceutical Law Firm India and Healthcare Law Firm India Reference Guide (2025)
FSSAI Bans “ORS” in Food Branding: Health Care Law Update & Healthcare Legal Consultant India Guide (2025)
HEALTH MINISTRY PROPOSES NEW RULES TO DIFFERENTIATE HOUSEHOLD AND HOSPITAL GRADE ANTISEPTICS
Scientific Promotion of Pharmaceuticals Products in India
THE REGULATORY FILING MA FOR FORMULATIONS IN THE EU
THE ENVIRONMENTAL, SOCIAL, AND GOVERNANCE (ESG) Understanding and Mitigating the Risk
The Doctrine of Equivalency Explained and Upheld
Compliance Requirements for Single-Use Plastic Guidelines
Dark Patterns Compliance
14 FDCs prohibited.
Voluntary Code of Conduct for E-Pharmacies in India
SOFTWARE AS A MEDICAL DEVICE – REGULATORY COMPLIANCES
Registration of Medical Practitioners and Licence to Practice Medicine Regulations, 2023
E-commerce Guidelines ON ONDC
MEIT REPORT OF COMMITTEE – B ON LEVERAGING AI FOR IDENTIFYING NATIONAL MISSIONS IN KEY SECTORS
COMPLIANCE FOR WHOLESALERS AND PACKERS UNDER LEGAL METROLOGY (PACKAGED COMMODITY) RULES 2011
PLANNING TO INTRODUCE SEXUAL WELLNESS TOYS
HIV Testing Laws and Compliances
DATA PROTECTION BILL COMPLIANCE
Privacy Policy Recommendations for E-Pharmacy
Artificial Intelligence in Healthcare Industry: ICMR Guidelines
ADVISORY ON DIGITAL PRESCRIPTION
Accessibility Guidelines Across Health Sector for Persons with Disabilities
KEY FEATURES OF THE RIGHTS OF PERSONS WITH DISABILITIES ACT, 2016
Whether one can sell and deliver cut-strip medicine in India?
E SHOP SHIPING CHARGE ON SALE OF DRUGS
Track & Trace for Pharmaceutical Products compliance
REPACKING OF DRUGS
QR CODE AND ANTI-COUNTERFEIT MEASURES
The sale of H1 Drugs by E-pharmacy site on the basis of a Narcotics License
Don’t Miss the Bus – EBA Guidelines and compulsory implementation
Uniform Code for Medical Device Marketing Practices
REGULATION OF SCHEDULE K DRUGS IN INDIA
Advertisement and Promotion of Pharma Products
